Akebia Therapeutics
AKBA
#7494
Rank
โ‚ฌ0.35 B
Marketcap
1,32ย โ‚ฌ
Share price
-3.14%
Change (1 day)
-31.70%
Change (1 year)

Revenue for Akebia Therapeutics (AKBA)

Revenue in 2025 (TTM): โ‚ฌ0.20 Billion

According to Akebia Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.19 Billion. In 2024 the company made a revenue of โ‚ฌ0.15 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ0.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Akebia Therapeutics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.20 B30.42%
2024 โ‚ฌ0.15 B-12.57%
2023 โ‚ฌ0.17 B-35.32%
2022 โ‚ฌ0.27 B44.32%
2021 โ‚ฌ0.18 B-21.45%
2020 โ‚ฌ0.24 B-19.72%
2019 โ‚ฌ0.29 B64.68%
2018 โ‚ฌ0.18 B22.42%
2017 โ‚ฌ0.14 B10064.79%
2016 โ‚ฌ1.45 M
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚ฌ30.89 B 15,882.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.41 B 24,946.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 40,842.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚ฌ53.76 M-72.19%๐Ÿ‡บ๐Ÿ‡ธ USA